10^th World Congress on Medicinal Chemistry and Drug Design June 14-15, 2018 Barcelona, Spain

Mario Ciampolini has completed his MD degree from Firenze University. He has been the Director of the unit of gastroeneterology in the pediatric Clinic of Firenze from the year 1966 till 2000. He has published more than 50 papers in reputed journals and has been serving as an Editorial Board Member of repute.

Medicinal Chemistry,

William G Whitford is Strategic Solutions Leader, GE Healthcare in Logan, UT with over 20 years of experience in biotechnology product and process development. He joined the company as an R&D Leader developing products supporting protein biological and vaccine production in mammalian and invertebrate cell lines. Products he has commercialized include defined hybridoma and perfusion cell culture media, fed-batch supplements and aqueous lipid dispersions. He has published over 250 articles, book chapters and patents in the bioproduction arena.

Biotechnology

Zhongli Gao is currently a Senior Principal Scientist at Sanofi. He received his PhD in Organic Chemistry from the City University of New York in 1993. Upon graduation, he carried out his Post-doctoral Research on the total synthesis of spinosyn-A supervised by Professor Paquette at Ohio State University. He joined Hoechst Pharmaceuticals, one of the predecessor companies of Sanofi in 1995. He has worked on a broad range of disease areas in CNS, respiratory, inflammation, oncology, and rare disease involving GPCRs, proteases, enzymes, kinases, ion channels and transporters. He has led many projects in advancing compounds into clinical and preclinical decisions.

Organic Chemistry

Nana Gorgaslidze has completed her PhD from Saint-Petersburg State Chemical-Pharmaceutical Academy. She is the Director of TSMU I Kutateladze Institute of Pharmacochemistry and Professor at the Department of Social and Clinical Pharmacy at Tbilisi State Medical University. She has published more than 80 papers in reputed journals.

Clinical Pharmacy, Pharmaceutical Chemistry

Ahmed Radwan has received his MSc and Doctoral degrees from Middlesex Business School in London. He also holds a first degree in Pharmacy and Pharmaceutical Sciences from Cairo University. He is an Adjunct Professor of Management at Edinburgh Business School, Herriot Watt University in the UK. He is also the Chairman and CEO of Pioneera HealthCare Group. He has over 25 years of experience within the pharmaceutical sector, including ethical pharmaceuticals, OTC, generics and strategic management consultation in the pharmaceutical field. He was the Marketing Director of Novartis, Regional Marketing Director of Otsuka and Regional Marketing Director of GSK.

Marketing

Dr. Alexander Heifetz is Principal Scientist at Evotec (UK) Ltd, a drug discovery services company and visiting scientist at University College London at the group of Prof Andrea Townsend-Nicholson. Alex has more than 15 years of experience in drug discovery industry and was involved in discovery of 4 clinical drug candidates for treatment of anxiety, major depressive disorder, pulmonary hypertension, and Alzheimer’s disease. He has more than 35 patents and 40 publications in the area of medicinal chemistry. In 2011 he received the Royal Society Industry Award for development of methods for GPCR modeling. In 2001 he obtained his PhD from the Weizmann Institute of Science.

Drug discovery

Olga I Lavrik has completed her graduation from Novosibirsk State University and post-doctoral studies and PhD from Institute of Bioorganic Chemistry in Moscow. She is the director of Laboratory of Bioorganic Chemistry of enzymes in the Institute of Chemical Biology and Fundamental Medicine of Russian Academy of Sciences. She is the professor of Novosibirsk State University. She has worked as a Visiting Professor at NIEHS (NC), Institute Jacques Monod, France and University of Évry Val d'Essonne, France. She has published more than 300 papers in reputed journals and has been serving as an Editorial Board of Journal of Molecular Biology and Biochemistry, Journal of Molecular Biology and as a Reviewer of Nucleic Acids Research, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Oncology Letters and other journals. She is a Member of Study Section of Russian Fund for Basic Research and Member of Federation of Biochemical Society. She is a Chancellor of European Environmental Mutagenesis and genomics Society. She is a State prize winner and correspondent member of Russian Academy of Sciences.

Bioorganic Chemistry

Maia Merlani has completed her PhD from Tbilisi State University. She is a senior research scientist at Tbilisi State Medical University. Her field of interest is a chemistry and synthesis of biologically active compounds. She is the author of more than 50 papers in reputed journals and presentations at 60 international scientific conferences. She was granted Georgian Presidential scholarship for young scientists (1997), NATO scholarship (2002, 2003) and Matsumae International foundation scholarship (2013). She is a member of organizing committee of several international conferences in the field of organic and pharmaceutical Chemistry.

Pharmaceutical Chemistry

Monika I Konaklieva has completed her PhD in Chemistry from SUNY Buffalo in 1997, and became a visiting professor in Medicinal Chemistry at Midwestern University, Chicago, Illinois (1997-1999). She is currently an associate professor at the American University. She has published more than 40 papers in reputed journals and has been serving as an Editorial Board Member of several chemistry journals publishing in the areas of organic and medicinal chemistry.

Organic and Medicinal chemistry

Concepción González-Bello has obtained her PhD from the University of Santiago de Compostela (USC, Spain) in 1994. She did two Pre-doctoral stays at the University of Gent (Belgium) with professor vandewalle and at the Scripps Research Institute (USA) with professor Nicolaou. After a Post-doctoral stay at the University of Cambridge (UK) with professor Abell, she joined USC as an assistant professor, was promoted to associate professor in 2003 and obtained the Spanish habilitation to Full professor in 2011. She joined the Center for Research in Biological Chemistry and Molecular Materials (CIQUS) as a group leader in 2011. She is the author of about 80 papers and several book chapters and an Academic Editor of Plos One. Her main research interest is to develop updated therapies targeting infectious diseases, in particular, drugs with new mechanisms of action to combat the growth of antibiotic-resistant bacteria.

Biological Chemistry and Molecular Materials